Acorda Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Acorda Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Acorda Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2024 was -236 %, a 828% decline year-over-year.
  • Acorda Therapeutics, Inc. annual Operating Margin for 2023 was -225 %, a 656% decline from 2022.
  • Acorda Therapeutics, Inc. annual Operating Margin for 2022 was -29.8 %, a 51.3% increase from 2021.
  • Acorda Therapeutics, Inc. annual Operating Margin for 2021 was -61.2 %, a 20% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -225 -195 -656% Jan 1, 2023 Dec 31, 2023
2022 -29.8 +31.4 +51.3% Jan 1, 2022 Dec 31, 2022
2021 -61.2 -10.2 -20% Jan 1, 2021 Dec 31, 2021
2020 -51 +111 +68.5% Jan 1, 2020 Dec 31, 2020
2019 -162 -170 -2084% Jan 1, 2019 Dec 31, 2019
2018 8.16 +47.7 Jan 1, 2018 Dec 31, 2018
2017 -39.6 -32.7 -471% Jan 1, 2017 Dec 31, 2017
2016 -6.92 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.